Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Huma
company
About
Huma provides a digital health platform used for predictive care and research.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Health Care,Information Technology,mHealth
- Founded date
- Aug 2, 2011
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Huma is a global health technology company that provides a modular platform to support digital 'hospitals at home' across different disease areas. Its platform combines predictive algorithms, digital biomarkers, and real-world data to advance proactive, predictive care and research.
The company was founded in 2011 and is headquartered in London, England.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$155M £25M
Huma has raised a total of
$155M £25M
in funding over 2 rounds. Their latest funding was raised on
Mar 23, 2022 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 23, 2022 | Corporate Round | £25M | 1 |
AstraZeneca
|
— | Detail |
| May 11, 2021 | Series C | $130M | 1 | — | — | Detail |
| Nov 5, 2019 | Series B | $25M | 1 |
Bayer
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Huma is funded by 3 investors.
AstraZeneca
and Bayer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
AstraZeneca
|
Yes | Corporate Round |
|
Bayer
|
Yes | Series B |
HAT Technology & Innovation Fund
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
